Remove Biopharma Remove Government Remove Legal Remove Life science
article thumbnail

Leveraging generative AI on AWS to transform life sciences

IBM Business Partners

Life sciences industry is beginning to take notice and aims to leapfrog the technological advances. Life sciences industry has—for decades now—moved from the traditional discovery-based drug development to target market-based drug development paradigm.

article thumbnail

Top 11 Chief Revenue Officer (CRO) Recruiters, Headhunters, and Executive Search Firms

Jake Jorgovan

With expertise in connecting organizations with top-tier executive talent, "Alliance International Services" is a trusted partner for businesses seeking CROs who can drive success in today's competitive landscape. With a wealth of expertise and resources, they offer a one-stop solution for businesses seeking top CRO talent and strategic HR support.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Growth Perspectives: Key Highlights from DCAT 2024

Frost & Sullivan

Simtra BioPharma Solutions announced over $250 million expansion of its sterile fill/finish manufacturing campus in Bloomington, Indiana. Growth Opportunity 2 – Medical Cannabidiol (CBD) Global regulatory shifts toward legalizing medical cannabis and CBD products highlight the growing interest in cannabis-based treatments.

article thumbnail

Is the Potential Threat of Shareholder Activism Heightened by the Pandemic?

LaVoie Health Science Blog

Sharp gains and losses in share prices, together with significant changes in share ownership mean that few companies, particularly those in the life science sector, are immune from the potential disruptions of shareholder activism. The COVID-19 pandemic has led to unprecedented volatility in equity markets.

Biotech 52